IQuity Labs Raises $2.35 Million

We represented IQuity Labs, a life science tech company, in its second round of seed financing totaling nearly $2.4 million. The capital will be used to open IQuity’s CLIA-certified laboratory in Nashville, Tennessee, and support the launch of IsolateMS – its first diagnostic test and the first RNA-based diagnostic test to detect multiple sclerosis. The investors in this round were not disclosed.

IQuity is a specialty diagnostic technology company leveraging machine learning methods to deliver breakthrough RNA analytics across neurology, gastroenterology and rheumatology.

You Also May Be Interested In:

  • Representation of Tennessee Community Bank Holdings, Inc., the parent company for Community Bank & Trust located in Ashland City, Tennessee, in its definitive agreement to sell to Reliant Bancorp, Inc. (Nasdaq: RBNC) for $37 million in an approximately 50% stock and 50% cash transaction.

    We represented Tennessee Community Bank Holdings, Inc., the parent company for Community Bank & Trust located in Ashland City, Tennessee,...
    Client Type: Private Company
  • We represented Mid-America Apartments, L.P., the operating partnership of Mid-America Apartment Communities, Inc., in a public offering of $250,000,000 of...
    Client Type: Public Company
  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company